Groups

Home Research group

RESEARCH GROUPS

Catalunya

arrow

HMRIB

Impact of the incentives and information system on general practitioner?s behavior, patients? health and the use of the health system

Funding entity:
Duration:

Impacto del programa poblacional de cribado mamográfico en la mortalidad por cáncer de mama.

Funding entity: Instituto Salud Carlos III (ISCiii)
Duration: 2023 hasta: 2027

Individual risk-stratified colorectal cancer screening: improving the yield of proposed strategies and enhancing risk knowledge and informed decision-making

Funding entity: Instituto Salud Carlos III (ISCiii)
Duration: 2026 hasta: 2028

Individual risk-stratified colorectal cancer screening: improving the yield of proposed strategies and enhancing risk knowledge and informed decision-making

Funding entity: Instituto Salud Carlos III (ISCiii)
Duration: 2026 hasta: 2026

Informe de Costes de las Recaídas Metastásicas de Cáncer de Mama en pacientes atendidas en el Hospital del Mar

Funding entity: Novartis Farmacéutica S.A.
Duration: 2025 hasta: 2025

International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 (MyPeBS)

Funding entity: European Commission
Duration: 2017 hasta: 2026

Long-term effectiveness of population-based colorectal cancer screening with fecal immunochemical test

Funding entity: Fundació Bancària La Caixa
Duration: 2026 hasta: 2028

Modelos predictivos de reingreso en insuficiencia cardiaca aguda descompensada (ICAD). Perfil del paciente que reingresa.

Funding entity:
Duration:

Patrones temporales de multimorbilidad, adherencia a las recomendaciones de seguimiento y uso de servicios sanitarios en una cohorte de supervivientes de cáncer de mama

Funding entity:
Duration:

Patrones temporales de multimorbilidad, adherencia a las recomendaciones de seguimiento y uso de servicios sanitarios en una cohorte de supervivientes de cáncer de mama

Funding entity: Instituto Salud Carlos III (ISCiii)
Duration: 2022 hasta: 2026

Personalised colorectal cancer screening: feasibility assessment of a tailored risk-based approach

Funding entity: Instituto Salud Carlos III (ISCiii)
Duration: 2020 hasta: 2025
© Ricapps 2026 | Desarrollado por VGS